HIV Immunotherapy Promising in First Human Study

HIV Immunotherapy Promising in First Human StudyAn experimental antibody significantly reduced HIV levels in infected people for as long as 28 days. The approach might help to combat a wide range of HIV strains.

HIV-infected immune cells. HIV Immunotherapy Promising in First Human Study
An experimental antibody significantly reduced HIV levels in infected people for as long as 28 days. The approach might help to combat a wide range of HIV strains.

SOURCE: NIH Research Matters – Read entire story here.